LSO Ideas To Action Life Sciences Forum

LSO Ideas To Action Life Sciences Forum 

LSO’s Annual Ideas to Action Life Sciences Forum (formerly LSO Policy Forum), will look at creating tangible actions that we can take to government and key stakeholders to help create a robust life sciences sector. Entering its 13th year, the forum will bring together key stakeholders from across the industry to strategize and collaborate on how we can empower the life sciences sector.

REGISTER NOW! 

Join us on October 5^th for a virtual pre-forum talk on “Creating a robust Life Sciences Strategy: Best Practice sharing between Denmark, Ontario, and Quebec”, more information can be found here.

On November 3^rd, we will do a deeper dive into how talent, data, and infrastructure can play key roles in the implementation of successful federal and provincial life sciences strategies.  What actions are needed to train and keep an inclusive talent field in Canada in order for the sector to grow? Data has the opportunity to positively impact research, the health systems, patients, government, and industry but how do we build strong data partnerships between all stakeholders? How do we ensure our infrastructure investments are sufficient to support the growing research, biomanufacturing, clinical trials, and coordinated data systems? We’ll end the day hearing from leading public policy strategists on how to action the ideas from the forum to ensure meaningful implementation.

Location:

November 3rd - Borden Ladner Gervais LLP

Bay Adelaide Centre, E. Tower – 22 Adelaide St W., 34th floor, Toronto, ON M5H 4E3

SPONSORSHIP

Sponsorship opportunities are available, click here for more details

PROGRAM

Click here to view the current program

Session Topics:

Opening Remarks

Hon. Vic Fedeli (Nipissing), Minister of Economic Development, Job Creation and Trade, Progressive Conservative Party of Ontario

Keynote – Bringing Strategy Home

Brigitte Nolet, President & CEO of Roche Canada Pharma will provide her insights and key learnings from her international experience. What can Canada learn from other international jurisdictions? How can we be competitive in the post-pandemic environment?

Coordinating Life Sciences Strategies Panel

This panel session will explore the interplay between federal and provincial life sciences strategies. How are these strategies co-dependent and will they be mutually reinforcing? How do we define areas of responsibility to ensure coordination within government and across different levels of government? What steps need to be implemented to ensure these strategies are meeting the needs of the life sciences sector?

Moderator: Brigitte Nolet, President & CEO, Roche Canada Pharma

• Jennifer Chan, Vice-President, Policy and Government Affairs, Merck Canada Inc
• Lesia Babiak, Head, Canada Government Affairs & Policy, Johnson & Johnson
• Darryl Patterson, Director General, Innovation, Science and Economic Development Canada - Life Sciences and Biomanufacturing branch
• Others TBC

Closing the Talent Gap Panel

BioTalent Canada predicts more than 65,000 new life sciences workers will be needed in Canada by 2029. In order to meet this demand, Canada’s life sciences sector must take steps to improve Inclusion, Diversity, Equity and Accessibility (IDEA). We need to train our young talent with the skills needed for the life sciences jobs of tomorrow and ensure that they have clear career development pathways to allow them to grow and succeed in the Canadian bioeconomy. This panel will explore the actions needed to bridge the talent gap.

Moderator: Reg Joseph, Chair, BioTalent Canada; CEO, Health Cities

• Christine Allen, Vice-President, Ecosystem Development, adMare Bioinnovations
• Tomas Baldassarre, Specialist Educational Development and Digital Learning, University of Ottawa
• Wendy Cukier, Founder & Academic Director; Professor, Entrepreneurship & Strategy, Toronto Metropolitan University
• Farah Qaiser, Member, Canada Chief Science Advisor’s Youth Council

Preparing for the Data Revolution Panel

Data and how we use it will fundamentally shape the life sciences sector in the immediate future. The potential for data to positively impact research, health systems, patients, government and industry hinge on the actions we take now. How do we build strong data partnerships between government, industry and the public? Do we have the right infrastructure and policy frameworks in place? Are we ready for the data revolution?

Moderator: Carole Piovesan, Managing Partner, INQ Law

• Alies Maybee, Co-founder and Chair, Patient Advisors Network
• Winson Cheung, Professor, University of Calgary
• Naheed Kurji, Co-Founder, President & CEO, Cyclica
• Michael Duong, Head of Innovation, Roche Canada

Investing in Life Sciences Infrastructure Panel

As jurisdictions around the world race to build strategies to grow investments in life sciences, are they overlooking the fundamental infrastructure needed support these investments and growth? Ontario is already struggling with access to wetlab space. Do we have other infrastructure to support increased life sciences research, biomanufacturing, clinical trials, and coordinated data systems? How do we ensure our infrastructure investments are sufficient to support our life sciences strategy goals?

Moderator: Maura Campbell, CEO, Ontario Bioscience Innovation Organization

• Daniel Lacey, Associate Vice President, CBRE | Life Sciences Practice Group
• Ty Shattuck, CEO, McMaster Innovation Park
• Janet Dancey, Director, Canadian Cancer Trials Group (CCTG); Professor, Department of Oncology, Queen’s University
• Speakers TBC

Turning Ideas to Action Panel

This fireside chat with leading public policy strategists will explore where we go from here. How do we action the ideas presented at this forum? How do we engage with government and other stakeholders to ensure meaningful implementation of life sciences strategies and beyond?

Moderator – Ryan Wiley, President, Shift Health

• Christine Elliott, Council, Fasken
• Jason Lietaer, President, Enterprise
• Ross Wallace, Principal, Santis Health
• Leah Cowen, Vice-President, Research and Innovation, and Strategic Initiatives, University of Toronto

Keynote Closing - Celebrating Alexion’s 30 years of Innovation in Rare Diseases

• Kathleen Whelan, Country Lead, International Government Affairs & Policy, Alexion Pharmaceuticals, Inc.
• Durhane Wong-Rieger, President & CEO at Canadian Organization for Rare Disorders (CORD)